Arrowhead Pharmaceuticals ARWR is set to give its latest quarterly earnings report on Monday, 2021-11-22. Here's what investors need to know before the announcement.
Analysts estimate that Arrowhead Pharmaceuticals will likely report an Earnings Per Share (EPS) of $-0.10
Arrowhead Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Past Earnings Performance
Last quarter the company missed EPS by $0.09, which was followed by a 4.79% drop in the share price the next day.
Here's a look at Arrowhead Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.20 | -0.13 | 0.17 | 0.12 |
| EPS Actual | -0.29 | -0.26 | -0.20 | -0.48 |
| Price Change % | -4.79% | -0.02% | 7.81% | -11.45% |
Stock Performance
Shares of Arrowhead Pharmaceuticals were trading at $70.75 as of November 18. Over the last 52-week period, shares are up 2.51%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
If you want to track all upcoming earnings announcements, check out our Earnings Calendar here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
